GlassScriptPhysician profile
Scott R Elkin
NPI 1265433080
$2,564.50
in general payments reported to CMS, 2019-2025
18 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,984 · 2022: $70.29 · 2023: $208 · 2024: $155 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $667.60 | 2019 | |
| Supernus Pharmaceuticals, INC. | $296.94 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $289.63 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $256.20 | 2019-2024 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $197.54 | 2019 | |
| Allergan, INC. | $196.98 | 2019 | |
| Sunovion Pharmaceuticals INC. | $183.80 | 2019 | |
| Vanda Pharmaceuticals INC. | $163.04 | 2019-2024 | Fanapt |
| Scilex Pharmaceuticals INC. | $64.43 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.84 | 2022 | |
| Kaleo, INC. | $40.27 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.05 | 2019-2023 | Spravato |
| Avanir Pharmaceuticals, INC. | $26.86 | 2019 | |
| Axsome Therapeutics, INC. | $24.13 | 2025 | Auvelity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $18.72 | 2019 | |
| Shire North American Group INC | $18.19 | 2019 | |
| Tris Pharma INC | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Elkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.